Lyn Baranowski
At a glance: Lyn Baranowski is CEO at Avalyn Pharma (AVLN). Their latest SEC Form 4, filed Nov 19, 2026, reported a sale of $1.1M. On file: 0 purchase lines ($0) and 5 sale lines ($1.5M).
CEO at Avalyn Pharma Inc. (AVLN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Lyn Baranowski's InsiderPrint
5 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 5 times a year, typically $149K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (5)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Anne McGeorgeDirector · DNTH · 100% match
- Bradley K. SerwinGeneral Counsel · COMP · 100% match
- Richard A. MedwayGeneral Counsel · SVV · 100% match
- Paul VarkiGeneral Counsel · AVTX · 100% match
- Gregory B. HebardCFO · JBL · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 19SEC | AVLNAvalyn Pharma Inc. | Sell Plan | 39,6005,700 held (−87%) | $27.76 | $1.1M | +3.3% |
| Nov 19SEC | AVLNAvalyn Pharma Inc. | Sell Plan | 5,300400 held (−93%) | $28.15 | $149K | +1.8% |
| Nov 19SEC | AVLNAvalyn Pharma Inc. | Sell Plan | 400 | $29.22 | $12K | -1.9% |
| Nov 19SEC | AVLNAvalyn Pharma Inc. | Sell Plan | 6,465735 held (−90%) | $27.90 | $180K | +2.7% |
| Nov 19SEC | AVLNAvalyn Pharma Inc. | Sell Plan | 735 | $28.36 | $21K | +1.1% |
- Sell
CEO Lyn Baranowski sold $1.1M of AVLN at $27.76 — cuts the stake by 87%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Lyn Baranowski sold $149K of AVLN at $28.15 — cuts the stake by 93%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Lyn Baranowski sold $12K of AVLN at $29.22 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Lyn Baranowski sold $180K of AVLN at $27.90 — cuts the stake by 90%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Lyn Baranowski sold $21K of AVLN at $28.36 — pre-scheduled 10b5-1 plan sale.
Follow Lyn Baranowski
Get one email when Lyn Baranowski files a new purchase or sale. Free.
At most one email a day about Lyn Baranowski, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.